Table 2.
Co‐bombardment | GFP cells* | GFP/GUS† |
---|---|---|
pUbiGUS+pGFP+pIPKTA30N | 951.5 ± 89.5 | 2.30 ± 0.18 (100) |
pUbiGUS+pGFP+pIPKTA30N_HvPrx40 | 812.0 ± 144.0 | 2.04 ± 0.25 (89) |
pUbiGUS+pGFP+pIPKTA30N_HO14J07‡ | 682.5 ± 30.5 | 1.89 ± 0.19 (82) |
pUbiGUS+pIPKTA40_HvPrx40deltaSP+pIPKTA30N | 37.0 ± 2.0 | 0.10 ± 0.01 (100) |
pUbiGUS+pIPKTA40_HvPrx40deltaSP+pIPKTA30N_HvPrx40 | 16.3 ± 6.3 | 0.03 ± 0.01 (30) |
pUbiGUS+pIPKTA40_HvPrx40deltaSP+pIPKTA30N_HO14J07 | 138.0 ± 10.5 | 0.35 ± 0.07 (359) |
Number of GFP‐expressing cells per bombardment. Means ± range of two independent experiments.
Ratio of GFP‐expressing to GUS‐expressing cells. Mean ± range of two independent experiments. Values in parentheses indicate relative values in percentage of the corresponding empty RNAi‐vector control.
Control RNAi construct targeting a transaldolase gene (represented by EST clone HO14J07).